Literature DB >> 31823093

Salivary inflammatory markers in tension type headache and migraine: the SalHead cohort study.

Anastasia Bougea1, Nikolaos Spantideas2, Petros Galanis2, Paraskevi Katsika2, Fotini Boufidou2, Panagiota Voskou2, Ioannis Vamvakaris2, Evangelos Anagnostou2, Xrysa Nikolaou2, Evangelia Kararizou2.   

Abstract

OBJECTIVE: To investigate the possible association between salivary CRP, IL-1β, and IL-6 levels, depression/anxiety and migraine, and tension type headache (TTH) in saliva of these patients.
METHOD: A longitudinal prospective study was conducted on 30 migraineurs, 30 TTH patients, and 30 age-matched healthy controls. Anxiety and depression were measured by using the Hamilton Anxiety Rating Scale (HAM-A), and the Beck Depression Inventory (BDI). Salivary IL-6, IL-1β, and CRP were collected in distinct time points as A: headache-free period, B: during headache, C: 1 day after headache attack, and measured by using ELISA kits.
RESULTS: No significant differences were found in time variation of CRP, IL-1β, and IL-6 levels between migraine and TTH (p > 0.05). IL1-β had the highest discriminative value (area under the curve = 0.924, p value < 0.001), and then CRP (area under the curve = 0.763, p value < 0.001) and IL-6 (area under the curve = 0.537, p value = 0.58). CRP and IL-6 were negatively correlated with HAM-A and BDI scores.
CONCLUSION: IL1-β had the highest discriminative value between headache patients and controls compared with CRP and IL-6. CRP and IL-6 were correlated with lower symptom scores of anxiety and depression prior or immediately after the headache period in patients groups.

Entities:  

Keywords:  Inflammation; Interleukin (IL)-1β; Interleukin IL-6; Migraine; Tension-type headache (TTH)

Mesh:

Substances:

Year:  2019        PMID: 31823093     DOI: 10.1007/s10072-019-04151-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  36 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Validation of a high-sensitivity assay for C-reactive protein in human saliva.

Authors:  I Ouellet-Morin; A Danese; B Williams; L Arseneault
Journal:  Brain Behav Immun       Date:  2011-01-12       Impact factor: 7.217

Review 3.  Salivary cortisol in psychoneuroendocrine research: recent developments and applications.

Authors:  C Kirschbaum; D H Hellhammer
Journal:  Psychoneuroendocrinology       Date:  1994       Impact factor: 4.905

4.  Associations Between Depression/Anxiety and Headache Frequency in Migraineurs: A Cross-Sectional Study.

Authors:  Hsuan-Te Chu; Chih-Sung Liang; Jiunn-Tay Lee; Ta-Chuan Yeh; Meei-Shyuan Lee; Yueh-Feng Sung; Fu-Chi Yang
Journal:  Headache       Date:  2017-10-18       Impact factor: 5.887

Review 5.  The global burden of headache: a documentation of headache prevalence and disability worldwide.

Authors:  Lj Stovner; K Hagen; R Jensen; Z Katsarava; Rb Lipton; Ai Scher; Tj Steiner; J-A Zwart
Journal:  Cephalalgia       Date:  2007-03       Impact factor: 6.292

6.  Assessing salivary C-reactive protein: longitudinal associations with systemic inflammation and cardiovascular disease risk in women exposed to intimate partner violence.

Authors:  Dorothée Out; Rosalie J Hall; Douglas A Granger; Gayle G Page; Stephanie J Woods
Journal:  Brain Behav Immun       Date:  2012-02-02       Impact factor: 7.217

7.  Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache.

Authors:  S H Bø; E M Davidsen; P Gulbrandsen; E Dietrichs; G Bovim; L J Stovner; L R White
Journal:  Cephalalgia       Date:  2008-10-22       Impact factor: 6.292

8.  Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran.

Authors:  Fahimeh Martami; Zeinab Ghorbani; Maryam Abolhasani; Mansoureh Togha; Alipasha Meysamie; Alireza Sharifi; Soodeh Razeghi Jahromi
Journal:  Neurol Sci       Date:  2017-10-11       Impact factor: 3.307

9.  High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients.

Authors:  Aynur Yilmaz Avci; Hatice Lakadamyali; Serap Arikan; Ulku Sibel Benli; Munire Kilinc
Journal:  J Headache Pain       Date:  2015-01-16       Impact factor: 7.277

10.  Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells.

Authors:  Lars Neeb; Peter Hellen; Jan Hoffmann; Ulrich Dirnagl; Uwe Reuter
Journal:  J Headache Pain       Date:  2016-03-01       Impact factor: 7.277

View more
  5 in total

1.  High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.

Authors:  Anastasia Bougea; Leonidas Stefanis; Evangelia Emmanouilidou; Kostas Vekrelis; Elisabeth Kapaki
Journal:  J Neural Transm (Vienna)       Date:  2020-01-07       Impact factor: 3.575

2.  Quality of life and psychological comorbidities in patients with migraine and hypertension.

Authors:  Thamires Sales Ribeiro; Luciana Salles Branco de Almeida; Vandilson Pinheiro Rodrigues; Caio Marcio Barros de Oliveira; Ed Carlos Rey Moura; Luciana Maia Moura Naves; Lidio Gonçalves Lima Neto; Leonardo Victor Galvão Moreira; Emanuel Cabral Pereira; Plínio da Cunha Leal
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

3.  Non-invasive diagnosis and monitoring tool of children's mental health: A point-of-care immunosensor for IL-6 quantification in saliva samples.

Authors:  Andrea Cruz; Maria Vieira; Ana R Mesquita; Adriana Sampaio; Inês Mendes-Pinto; Isabel Soares; Paulo P Freitas
Journal:  Front Neurosci       Date:  2022-09-26       Impact factor: 5.152

4.  Evaluation of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and C-Reactive Protein in Tension-Type Headache Patients.

Authors:  Hasan Hüseyin Özdemir; Ahmet Dönder
Journal:  J Neurosci Rural Pract       Date:  2021-06-15

5.  Previous History of Migraine Is Associated With Fatigue, but Not Headache, as Long-Term Post-COVID Symptom After Severe Acute Respiratory SARS-CoV-2 Infection: A Case-Control Study.

Authors:  César Fernández-de-Las-Peñas; Víctor Gómez-Mayordomo; David García-Azorín; Domingo Palacios-Ceña; Lidiane L Florencio; Angel L Guerrero; Valentín Hernández-Barrera; María L Cuadrado
Journal:  Front Hum Neurosci       Date:  2021-06-28       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.